메뉴 건너뛰기




Volumn 195, Issue , 2011, Pages 128-137

Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn)

Author keywords

Alpha synuclein; Macroautophagy; Oxidative stress; Parkinson's disease; Proteasome; Protein aggregation

Indexed keywords

3 METHYLADENINE; ALPHA SYNUCLEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; HYDROGEN PEROXIDE; PROTEASOME;

EID: 80053561992     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.08.030     Document Type: Article
Times cited : (21)

References (50)
  • 1
    • 9444272812 scopus 로고    scopus 로고
    • Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70
    • Albani D., Peverelli E., Rametta R., Batelli S., Veschini L., Negro A., Forloni G. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70. FASEB J 2004, 18:1713-1715.
    • (2004) FASEB J , vol.18 , pp. 1713-1715
    • Albani, D.1    Peverelli, E.2    Rametta, R.3    Batelli, S.4    Veschini, L.5    Negro, A.6    Forloni, G.7
  • 2
    • 78650505110 scopus 로고    scopus 로고
    • Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation
    • Anderson V.L., Ramlall T.F., Rospigliosi C.C., Webb W.W., Eliezer D. Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation. Proc Natl Acad Sci U S A 2010, 107:18850-18855.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 18850-18855
    • Anderson, V.L.1    Ramlall, T.F.2    Rospigliosi, C.C.3    Webb, W.W.4    Eliezer, D.5
  • 5
    • 0034681163 scopus 로고    scopus 로고
    • Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy
    • Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Williamson R.E., Lansbury P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 2000, 97:571-576.
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 571-576
    • Conway, K.A.1    Lee, S.J.2    Rochet, J.C.3    Ding, T.T.4    Williamson, R.E.5    Lansbury, P.T.6
  • 6
    • 0038624450 scopus 로고    scopus 로고
    • Parkin's substrates and the pathways leading to neuronal damage
    • Cookson M.R. Parkin's substrates and the pathways leading to neuronal damage. Neuromol Med 2003, 3:1-13.
    • (2003) Neuromol Med , vol.3 , pp. 1-13
    • Cookson, M.R.1
  • 7
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: mechanisms and models
    • Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
    • (2003) Neuron , vol.39 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 8
    • 0042521076 scopus 로고    scopus 로고
    • The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
    • Di Monte D.A. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?. Lancet Neurol 2003, 2:531-538.
    • (2003) Lancet Neurol , vol.2 , pp. 531-538
    • Di Monte, D.A.1
  • 9
    • 0036670712 scopus 로고    scopus 로고
    • Aggregation and neurotoxicity of alpha-synuclein and related peptides
    • el-Agnaf O.M., Irvine G.B. Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem Soc Trans 2002, 30:559-565.
    • (2002) Biochem Soc Trans , vol.30 , pp. 559-565
    • el-Agnaf, O.M.1    Irvine, G.B.2
  • 11
    • 0038727936 scopus 로고    scopus 로고
    • Description of Parkinson's disease as a clinical syndrome
    • Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003, 991:1-14.
    • (2003) Ann N Y Acad Sci , vol.991 , pp. 1-14
    • Fahn, S.1
  • 13
    • 68649110032 scopus 로고    scopus 로고
    • Mendelian forms of Parkinson's disease
    • Gasser T. Mendelian forms of Parkinson's disease. Biochim Biophys Acta 2009, 1792:587-596.
    • (2009) Biochim Biophys Acta , vol.1792 , pp. 587-596
    • Gasser, T.1
  • 14
    • 0038784529 scopus 로고    scopus 로고
    • Are ubiquitination pathways central to Parkinson's disease?
    • Giasson B.I., Lee V.M. Are ubiquitination pathways central to Parkinson's disease?. Cell 2003, 114:1-8.
    • (2003) Cell , vol.114 , pp. 1-8
    • Giasson, B.I.1    Lee, V.M.2
  • 15
    • 0037192865 scopus 로고    scopus 로고
    • Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells
    • Hashimoto M., Hsu L.J., Rockenstein E., Takenouchi T., Mallory M., Masliah E. Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 2002, 277:11465-11472.
    • (2002) J Biol Chem , vol.277 , pp. 11465-11472
    • Hashimoto, M.1    Hsu, L.J.2    Rockenstein, E.3    Takenouchi, T.4    Mallory, M.5    Masliah, E.6
  • 16
    • 0038389601 scopus 로고    scopus 로고
    • Transgenic models of alpha-synuclein pathology: past, present, and future
    • Hashimoto M., Rockenstein E., Masliah E. Transgenic models of alpha-synuclein pathology: past, present, and future. Ann N Y Acad Sci 2003, 991:171-188.
    • (2003) Ann N Y Acad Sci , vol.991 , pp. 171-188
    • Hashimoto, M.1    Rockenstein, E.2    Masliah, E.3
  • 17
    • 0037237927 scopus 로고    scopus 로고
    • Oxidative stress and nitration in neurodegeneration: cause, effect, or association?
    • Ischiropoulos H., Beckman J.S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J Clin Invest 2003, 111:163-169.
    • (2003) J Clin Invest , vol.111 , pp. 163-169
    • Ischiropoulos, H.1    Beckman, J.S.2
  • 18
    • 0032500599 scopus 로고    scopus 로고
    • Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
    • Jensen P.H., Nielsen M.S., Jakes R., Dotti C.G., Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 1998, 273:26292-26294.
    • (1998) J Biol Chem , vol.273 , pp. 26292-26294
    • Jensen, P.H.1    Nielsen, M.S.2    Jakes, R.3    Dotti, C.G.4    Goedert, M.5
  • 19
    • 0037971160 scopus 로고    scopus 로고
    • Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity
    • Jensen P.J., Alter B.J., O'Malley K.L. Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J Neurochem 2003, 86:196-209.
    • (2003) J Neurochem , vol.86 , pp. 196-209
    • Jensen, P.J.1    Alter, B.J.2    O'Malley, K.L.3
  • 20
    • 79951536222 scopus 로고    scopus 로고
    • Alpha-synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity
    • Jin H., Kanthasamy A., Ghosh A., Yang Y., Anantharam V., Kanthasamy A.G. Alpha-synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J Neurosci 2011, 31:2035-2051.
    • (2011) J Neurosci , vol.31 , pp. 2035-2051
    • Jin, H.1    Kanthasamy, A.2    Ghosh, A.3    Yang, Y.4    Anantharam, V.5    Kanthasamy, A.G.6
  • 21
    • 0037137224 scopus 로고    scopus 로고
    • Structural and functional implications of C-terminal regions of alpha-synuclein
    • Kim T.D., Paik S.R., Yang C.H. Structural and functional implications of C-terminal regions of alpha-synuclein. Biochemistry 2002, 41:13782-13790.
    • (2002) Biochemistry , vol.41 , pp. 13782-13790
    • Kim, T.D.1    Paik, S.R.2    Yang, C.H.3
  • 22
    • 0034492520 scopus 로고    scopus 로고
    • Structural changes in alpha-synuclein affect its chaperone-like activity in vitro
    • Kim T.D., Paik S.R., Yang C.H., Kim J. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci 2000, 9:2489-2496.
    • (2000) Protein Sci , vol.9 , pp. 2489-2496
    • Kim, T.D.1    Paik, S.R.2    Yang, C.H.3    Kim, J.4
  • 24
    • 77957371012 scopus 로고    scopus 로고
    • Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection
    • Lee H.J., Kim C., Lee S.J. Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection. Oxid Med Cell Longev 2010, 3:283-287.
    • (2010) Oxid Med Cell Longev , vol.3 , pp. 283-287
    • Lee, H.J.1    Kim, C.2    Lee, S.J.3
  • 25
    • 0042477558 scopus 로고    scopus 로고
    • Alpha-synuclein and presynaptic function: implications for Parkinson's disease
    • Lykkebo S., Jensen P.H. Alpha-synuclein and presynaptic function: implications for Parkinson's disease. Neuromol Med 2002, 2:115-129.
    • (2002) Neuromol Med , vol.2 , pp. 115-129
    • Lykkebo, S.1    Jensen, P.H.2
  • 26
  • 27
    • 0038711511 scopus 로고    scopus 로고
    • Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications
    • Norris E.H., Giasson B.I., Ischiropoulos H., Lee V.M. Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J Biol Chem 2003, 278:27230-27240.
    • (2003) J Biol Chem , vol.278 , pp. 27230-27240
    • Norris, E.H.1    Giasson, B.I.2    Ischiropoulos, H.3    Lee, V.M.4
  • 28
    • 79953236488 scopus 로고    scopus 로고
    • Synuclein modulation of monoamine transporters
    • Oaks A.W., Sidhu A. Synuclein modulation of monoamine transporters. FEBS Lett 2011, 585:1001-1006.
    • (2011) FEBS Lett , vol.585 , pp. 1001-1006
    • Oaks, A.W.1    Sidhu, A.2
  • 30
    • 0037047371 scopus 로고    scopus 로고
    • Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone
    • Park S.M., Jung H.Y., Kim T.D., Park J.H., Yang C.H., Kim J. Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone. J Biol Chem 2002, 277:28512-28520.
    • (2002) J Biol Chem , vol.277 , pp. 28512-28520
    • Park, S.M.1    Jung, H.Y.2    Kim, T.D.3    Park, J.H.4    Yang, C.H.5    Kim, J.6
  • 32
    • 79955807710 scopus 로고    scopus 로고
    • Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress
    • Riedel M., Goldbaum O., Wille M., Richter-Landsberg C. Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress. J Mol Neurosci 2011, 43:290-302.
    • (2011) J Mol Neurosci , vol.43 , pp. 290-302
    • Riedel, M.1    Goldbaum, O.2    Wille, M.3    Richter-Landsberg, C.4
  • 33
    • 0032192146 scopus 로고    scopus 로고
    • Recent advances in inducible gene expression systems
    • Rossi F.M., Blau H.M. Recent advances in inducible gene expression systems. Curr Opin Biotechnol 1998, 9:451-456.
    • (1998) Curr Opin Biotechnol , vol.9 , pp. 451-456
    • Rossi, F.M.1    Blau, H.M.2
  • 35
    • 77953796839 scopus 로고    scopus 로고
    • A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration
    • Scott D.A., Tabarean I., Tang Y., Cartier A., Masliah E., Roy S. A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J Neurosci 2010, 30:8083-8095.
    • (2010) J Neurosci , vol.30 , pp. 8083-8095
    • Scott, D.A.1    Tabarean, I.2    Tang, Y.3    Cartier, A.4    Masliah, E.5    Roy, S.6
  • 37
    • 0037229425 scopus 로고    scopus 로고
    • Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
    • Sherer T.B., Kim J.H., Betarbet R., Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003, 179:9-16.
    • (2003) Exp Neurol , vol.179 , pp. 9-16
    • Sherer, T.B.1    Kim, J.H.2    Betarbet, R.3    Greenamyre, J.T.4
  • 39
    • 70349503591 scopus 로고    scopus 로고
    • Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein
    • Uversky V.N., Eliezer D. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci 2009, 10:483-499.
    • (2009) Curr Protein Pept Sci , vol.10 , pp. 483-499
    • Uversky, V.N.1    Eliezer, D.2
  • 40
    • 53049098471 scopus 로고    scopus 로고
    • Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells
    • Vogiatzi T., Xilouri M., Vekrellis K., Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008, 283:23542-23556.
    • (2008) J Biol Chem , vol.283 , pp. 23542-23556
    • Vogiatzi, T.1    Xilouri, M.2    Vekrellis, K.3    Stefanis, L.4
  • 41
    • 0038386274 scopus 로고    scopus 로고
    • Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease
    • Volles M.J., Lansbury P.T. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 2003, 42:7871-7878.
    • (2003) Biochemistry , vol.42 , pp. 7871-7878
    • Volles, M.J.1    Lansbury, P.T.2
  • 42
    • 0037379324 scopus 로고    scopus 로고
    • Genetic and environmental factors in the cause of Parkinson's disease
    • Warner T.T., Schapira A.H. Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 2003, 53(Suppl 3):S16-S23.
    • (2003) Ann Neurol , vol.53 , Issue.SUPPL 3
    • Warner, T.T.1    Schapira, A.H.2
  • 43
    • 0141726844 scopus 로고    scopus 로고
    • Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity
    • Wersinger C., Prou D., Vernier P., Niznik H.B., Sidhu A. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Mol Cell Neurosci 2003, 24:91-105.
    • (2003) Mol Cell Neurosci , vol.24 , pp. 91-105
    • Wersinger, C.1    Prou, D.2    Vernier, P.3    Niznik, H.B.4    Sidhu, A.5
  • 45
    • 77956596883 scopus 로고    scopus 로고
    • Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease
    • Xie W., Li X., Li C., Zhu W., Jankovic J., Le W. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease. J Neurochem 2010, 115:188-199.
    • (2010) J Neurochem , vol.115 , pp. 188-199
    • Xie, W.1    Li, X.2    Li, C.3    Zhu, W.4    Jankovic, J.5    Le, W.6
  • 46
    • 65849127844 scopus 로고    scopus 로고
    • Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy
    • Xilouri M., Vogiatzi T., Vekrellis K., Park D., Stefanis L. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 2009, 4(5):e5515.
    • (2009) PLoS One , vol.4 , Issue.5
    • Xilouri, M.1    Vogiatzi, T.2    Vekrellis, K.3    Park, D.4    Stefanis, L.5
  • 47
    • 53549118274 scopus 로고    scopus 로고
    • Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis
    • Xilouri M., Vogiatzi T., Vekrellis K., Stefanis L. Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis. Autophagy 2008, 4:917-919.
    • (2008) Autophagy , vol.4 , pp. 917-919
    • Xilouri, M.1    Vogiatzi, T.2    Vekrellis, K.3    Stefanis, L.4
  • 48
    • 58149215720 scopus 로고    scopus 로고
    • Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy
    • Yang Q., She H., Gearing M., Colla E., Lee M., Shacka J.J., Mao Z. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009, 323:124-127.
    • (2009) Science , vol.323 , pp. 124-127
    • Yang, Q.1    She, H.2    Gearing, M.3    Colla, E.4    Lee, M.5    Shacka, J.J.6    Mao, Z.7
  • 49
    • 80051591601 scopus 로고    scopus 로고
    • C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells
    • Yin J., Han J., Zhang C., Ma Q.L., Li X., Cheng F., Liu G., Li Y., Uéda K., Chan P., Yu S. C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells. J Neural Transm 2011, 118:1155-1164.
    • (2011) J Neural Transm , vol.118 , pp. 1155-1164
    • Yin, J.1    Han, J.2    Zhang, C.3    Ma, Q.L.4    Li, X.5    Cheng, F.6    Liu, G.7    Li, Y.8    Uéda, K.9    Chan, P.10    Yu, S.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.